Form 4: Vertex Pharmaceuticals Executive Amit Sachdev Reports Stock Disposal
SEC Form 4 Filing
Amit Sachdev, EVP Chief Patient & External Affairs Officer at Vertex Pharmaceuticals, reported the disposal of 2,056 shares of common stock to cover tax obligations.
Summary
- On February 10, 2025, Amit Sachdev, an executive at Vertex Pharmaceuticals, disposed of 2,056 shares of common stock.
- The transaction was executed at a price of $467.98 per share.
- Following the transaction, Sachdev directly owns 70,591 shares of Vertex Pharmaceuticals common stock.
- Sachdev also indirectly owns 882 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a neutral filing related to an executive's stock transaction. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of insider transactions. This filing indicates that an executive at Vertex Pharmaceuticals disposed of shares, which could be for various reasons, including tax obligations or portfolio diversification.
Key Dates
| Date | Description |
|---|---|
| 02/10/2025 | Date of stock disposal transaction |
| 02/12/2025 | Date of signature by Attorney-in-Fact |
Keywords
Form 4, Beneficial Ownership, Stock Disposal, Vertex Pharmaceuticals, VRTX, Amit Sachdev, Executive Compensation, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.